Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts.
Derikx LAAP, Dolby HW, Plevris N, Lucaciu L, Rees CS, Lyons M, Siakavellas SI, Constantine-Cooke N, Jenkinson P, Su S, O'Hare C, Kirckpatrick L, Merchant LM, Noble C, Arnott ID, Jones GR, Lees CW. Derikx LAAP, et al. Among authors: arnott id. J Crohns Colitis. 2021 Dec 18;15(12):2011-2021. doi: 10.1093/ecco-jcc/jjab100. J Crohns Colitis. 2021. PMID: 34089587 Free PMC article.
Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe.
Van Limbergen J, Russell RK, Nimmo ER, Törkvist L, Lees CW, Drummond HE, Smith L, Anderson NH, Gillett PM, McGrogan P, Hassan K, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Sjöqvist U, Lördal M, Farrington SM, Dunlop MG, Wilson DC, Satsangi J. Van Limbergen J, et al. Among authors: arnott id. Inflamm Bowel Dis. 2007 Jul;13(7):882-9. doi: 10.1002/ibd.20124. Inflamm Bowel Dis. 2007. PMID: 17285593
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, Boulton-Jones R, Williams A, Church N, Satsangi J, Arnott ID; Scottish Society of Gastroenterology Infliximab Group. Lees CW, et al. Among authors: arnott id. Aliment Pharmacol Ther. 2007 Aug 1;26(3):411-9. doi: 10.1111/j.1365-2036.2007.03383.x. Aliment Pharmacol Ther. 2007. PMID: 17635376
The use of adalimumab in the management of refractory Crohn's disease.
Ho GT, Smith L, Aitken S, Lee HM, Ting T, Fennell J, Lees CW, Palmer KR, Penman ID, Shand AG, Arnott ID, Satsangi J. Ho GT, et al. Among authors: arnott id. Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15. doi: 10.1111/j.1365-2036.2007.03583.x. Epub 2007 Dec 7. Aliment Pharmacol Ther. 2008. PMID: 18081730 Clinical Trial.
Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways.
Lees CW, Zacharias WJ, Tremelling M, Noble CL, Nimmo ER, Tenesa A, Cornelius J, Torkvist L, Kao J, Farrington S, Drummond HE, Ho GT, Arnott ID, Appelman HD, Diehl L, Campbell H, Dunlop MG, Parkes M, Howie SE, Gumucio DL, Satsangi J. Lees CW, et al. Among authors: arnott id. PLoS Med. 2008 Dec 9;5(12):e239. doi: 10.1371/journal.pmed.0050239. PLoS Med. 2008. PMID: 19071955 Free PMC article.
133 results